City Of Hope's Joseph Alvarnas On CAR-T Real-World Use, Reimbursement

 
• By Mandy Jackson

City of Hope hematologist/oncologist Joseph Alvarnas shares his perspectives on how CAR-T therapies are requiring new models of health care delivery and engagement with more kinds of stakeholders, during an interview at the recent ASH annual meeting.

Joseph Alvarnas at ASH
Joseph Alvarnas, City of Hope • Source: Courtesy of ASH

More from Immuno-oncology

More from Anticancer